Akinobu Yoshimura - Concepedia

Author

Akinobu Yoshimura

Nippon Medical School

Also Known As

AKINOBU YOSHIMURA, Akinobu YOSHIMURA, Akinobu Yoshimura

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Nippon Medical School Tokyo Medical University Hospital Nippon Medical School Hospital Tokyo Medical University Saitama Medical University

About

Akinobu Yoshimura is an author at Nippon Medical School specializing in medicine, lung cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	918
2	Health Sciences	3	3	78
3	Engineering	1	1	64
4	Natural Sciences	1	1	41
5	Applied Physics	1	1	64

Akinobu Yoshimura

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells Mengru Cao, Masahiro Seike, Chie Soeno, International Journal of Oncology Cancer BiologyTumor BiologyEpithelial-mesenchymal TransitionTissue DevelopmentCancer Cell Biology	2012	168
The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias Yuji Minegishi, Junko Sudoh, Hideaki Kuribayasi, Lung Cancer MedicineCancer ManagementWeekly PaclitaxelBronchial NeoplasmCancer Treatment	2010	145
Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy Yuji Minegishi, K. Takenaka, Hideki Mizutani, Internal Medicine	2009	130
Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model Akihiko Miyanaga, Akihiko Gemma, Rintaro Noro, Molecular Cancer Therapeutics	2008	95
Somatic mutation of thehBUB1 mitotic checkpoint gene in primary lung cancer Akihiko Gemma, Masahiro Seike, Yoko Seike, Genes Chromosomes and Cancer	2000	82
The Feasibility Study of Carboplatin Plus Etoposide for Advanced Small Cell Lung Cancer with Idiopathic Interstitial Pneumonias Yuji Minegishi, Hidehiko Kuribayashi, Kazuhiro Kitamura, Journal of Thoracic Oncology Advanced Lung DiseaseMedicineImmunologyPathologyPulmonary Fibrosis	2011	71
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation Rintaro Noro, Akihiko Gemma, Seiji Kosaihira, BMC Cancer	2006	66
Phase I study of E7010 Kaichiro Yamamoto, Kiichiro Noda, Akinobu Yoshimura, Cancer Chemotherapy and Pharmacology EngineeringPhase EquilibriumExperimental AnalysisApplied PhysicsInstrumentation	1998	64
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors Shoji Kudoh, Akinobu Yoshimura, Kiyoko Kataoka, International Journal of Oncology EpigeneticsTumor BiologyReceptor Tyrosine KinaseOncogenic AgentCell Lines	2007	53
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation Akihiko Miyanaga, K Shimizu, Rintaro Noro, BMC Cancer	2013	53

Page 1